MAIA
Price
$1.48
Change
+$0.04 (+2.78%)
Updated
Jul 13, 11:56 AM (EDT)
Capitalization
87.55M
29 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$9.74
Change
-$0.22 (-2.21%)
Updated
Jul 13, 12:04 PM (EDT)
Capitalization
1.68B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MAIA vs VIR

MAIA vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MAIA vs. VIR commentary
Jul 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAIA is a Buy and VIR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2026
Stock price -- (MAIA: $1.44 vs. VIR: $9.96)
Brand notoriety: MAIA and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MAIA: 66% vs. VIR: 90%
Market capitalization -- MAIA: $87.55M vs. VIR: $1.68B
MAIA [@Biotechnology] is valued at $87.55M. VIR’s [@Biotechnology] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $123.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MAIA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • MAIA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than MAIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MAIA’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 6 bullish TA indicator(s).

  • MAIA’s TA Score: 5 bullish, 3 bearish.
  • VIR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both MAIA and VIR are a good buy in the short-term.

Price Growth

MAIA (@Biotechnology) experienced а -0.69% price change this week, while VIR (@Biotechnology) price change was -0.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.29%. For the same industry, the average monthly price growth was +8.22%, and the average quarterly price growth was +1918.92%.

Reported Earning Dates

MAIA is expected to report earnings on Aug 11, 2026.

VIR is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-2.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($1.68B) has a higher market cap than MAIA($87.6M). VIR YTD gains are higher at: 65.174 vs. MAIA (-5.882). MAIA has higher annual earnings (EBITDA): -23.71M vs. VIR (-460.62M). VIR has more cash in the bank: 476M vs. MAIA (34.4M). VIR has higher revenues than MAIA: VIR (64.7M) vs MAIA (0).
MAIAVIRMAIA / VIR
Capitalization87.6M1.68B5%
EBITDA-23.71M-460.62M5%
Gain YTD-5.88265.174-9%
P/E RatioN/AN/A-
Revenue064.7M-
Total Cash34.4M476M7%
Total DebtN/A95.6M-
FUNDAMENTALS RATINGS
VIR: Fundamental Ratings
VIR
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MAIAVIR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 21 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
MAIA
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPAYX12.660.10
+0.80%
Integrity Dividend Summit I
BLYRX41.630.13
+0.31%
American Beacon Man Lg Cp Growth R6
HGOFX79.120.16
+0.20%
Hartford Growth Opportunities F
TINFX28.930.02
+0.07%
Thornburg International Growth R5
TQSAX29.92-0.04
-0.13%
T. Rowe Price Integrated US SMCC Eq Adv

MAIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAIA has been loosely correlated with CRVS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MAIA jumps, then CRVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
-1.37%
CRVS - MAIA
34%
Loosely correlated
-3.27%
RNA - MAIA
32%
Poorly correlated
-3.49%
VIR - MAIA
32%
Poorly correlated
-3.68%
ACRS - MAIA
30%
Poorly correlated
-2.28%
CADL - MAIA
29%
Poorly correlated
-4.04%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-3.68%
BEAM - VIR
54%
Loosely correlated
-8.77%
PCVX - VIR
52%
Loosely correlated
-2.71%
DNLI - VIR
51%
Loosely correlated
-5.62%
RCUS - VIR
50%
Loosely correlated
-3.47%
XNCR - VIR
50%
Loosely correlated
-1.64%
More